Figure 5 shows the ELISA result of HGF quantification; it is clear that NASH patients present a significant increase in circulating levels of HGF; these data suggest that HGF/c-Met signaling is required for a proper response against NASH in humans where free cholesterol is frequently accumulated. This evidence concerns the gene HGF and metabolic dysfunction-associated steatohepatitis.